vor 2 Jahren

Cluster Healthcare Industries Berlin-Brandenburg

  • Text
  • Germany
  • Pharma
  • Technology
  • Medicine
  • Healthcare
  • Cluster
  • Berlin
  • Biotechnology
  • Industries
  • Innovative
  • Hospitals
  • Tourism

6 Biotechnology and

6 Biotechnology and Pharmaceuticals Biotechnology and Pharmaceuticals 7 Focal area 1 Biotechnology and Pharmaceuticals Biotechnology is a key driver of innovation in the region. The industry has recorded steady growth and a high level of startup dynamics; many of the biotech companies were established on site from local universities and research institutions. This is especially true for "red" biotechnology, which deals with medicine: Of the more than 240 biotechnology companies with approx. 5,000 employees, about 90% are active in biomedicine. They develop innovative therapeutic and diagnostic procedures to treat cancer, cardiovascular diseases and diabetes, and benefit from the strong scientific background and excellent infrastructure for clinical studies in the region. The know-how and local opportunities make the capital region attractive for global pharmaceutical companies: They can develop and produce innovative medicines here. In addition to drug development, bioanalytics and diagnostics, the Berlin-Brandenburg region has also become one of the most important centers for regenerative medicine with outstanding research in the fundamentals of biomedicines and biomaterials in Germany. The Berlin Institute of Health (BIH) has emerged as an internationally visible research and translation center that sets new standards in systemic medicine thanks to the increasingly close collaboration between the Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine. Strategic goals Develop the capital region into one of the leading European sites for biotechnology and pharmaceuticals. Lead the way for the design of joint research and development activities. Strengthen the transfer of technology. Open up new areas of growth in the life sciences. Main fields of focus Drug development Diagnostics Regenerative medicine Glycobiotechnology Industrial biotechnology At a glance 30 pharmaceutical companies with approx. 10,000 employees Approx. 240 biotech companies with around 5,000 employees High level of startup dynamics 9 technology parks focusing on life sciences Excellent conditions for clinical research Interdisciplinary cooperation in the areas of biotechnology, diagnostics, pharmaceuticals, medtech, photonics and IT Cooperation as part of industry networks Good access to skilled specialists

Publications in English

Publikationen auf deutsch

Clusterreport Verkehr, Mobilität und Logistik
Automotive in der Hauptstadtregion Berlin-Brandenburg
Aerospace Industrie
Biotech- und Pharmaindustrie
Forschung für die Gesundheit
Gesundheitsversorgung und Prävention
Potenzialstudie Medizintourismus Berlin-Brandenburg_2015
Clusterbroschuere Gesundheitswirtschaft
Prävention und Gesundheitsförderung
Rehabilitation in Berlin und Brandenburg
Games Industrie in der Hauptstadtregion Berlin-Brandenburg
Digitale Wirtschaft in Berlin
Fernsehen in der Hauptstadtregion Berlin-Brandenburg
Fashion in Berlin
Best Practice Wireless in der Hauptstadtregion Berlin-Brandenburg
Medien und Kreativwirtschaft in Berlin-Brandenburg
Turbomaschinen und Kraftwerkstechnik
Energienetze und -speicher in der Hauptstadtregion Berlin-Brandenburg
Kreislaufwirtschaft in Berlin
Wasserwirtschaft in Berlin
Energietechnik in der Hauptstadtregion Berlin-Brandenburg
Inkubationsprogramme in der Energiewirtschaft
Service Packages für Unternehmen in Berlin
Unternehmensservice in den Berliner Bezirken
Berlin Partner: Unser Service fuer Sie